Coley's Toxins in Perspective

Overview

Journal Nature

Specialty Science

Date 1992 May 7

PMID 1574121

Citations 100

Authors

C O Starnes

Affiliations

Soon will be listed here.

Abstract

Despite initial hopes, the efficacy of tumour necrosis factor in treating cancer patients has been disappointing. But a more careful selection of patients, and more appropriate treatment, might be fruitful.

Citing Articles

Development of a bacteria-nanosapper for the active delivery of ZIF-8 particles containing therapeutic genes for cancer immune therapy.

Qiao Y, Luo M, Wang Y, Qi H, Wang M, Pei Y Acta Pharm Sin B. 2025; 14(12):5418-5434.

PMID: 39807327 PMC: 11725029. DOI: 10.1016/j.apsb.2024.07.020.

Tumor cell membrane-based vaccines: A potential boost for cancer immunotherapy.

Yang M, Zhou J, Lu L, Deng D, Huang J, Tang Z Exploration (Beijing). 2024; 4(6):20230171.

PMID: 39713208 PMC: 11655317. DOI: 10.1002/EXP.20230171.

Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity.

Copland A, Mackie G, Scarfe L, Jinks E, Lecky D, Gudgeon N EMBO Mol Med. 2024; 16(12):3057-3088.

PMID: 39558103 PMC: 11628626. DOI: 10.1038/s44321-024-00159-2.

Effects and mechanisms of on cancers development and immunotherapy.

Zhong X, Zheng H, Zhao S, Wang Z, Su Y, Zhong K Front Immunol. 2024; 15:1469096.

PMID: 39434880 PMC: 11491387. DOI: 10.3389/fimmu.2024.1469096.

Abscopal effect: from a rare phenomenon to a new frontier in cancer therapy.

Wang X, Zhang H, XinZhang , Liu Y Biomark Res. 2024; 12(1):98.

PMID: 39228005 PMC: 11373306. DOI: 10.1186/s40364-024-00628-3.